A good response to NET defined as a decrease in tumour size and/or decrease of Ki‐67 was found to be associated with a longer duration of NET, a change of CD4+ T‐cells, and a higher number of CD68+ tumour‐associated macrophages before the start of NET. The gene discussed is CD4; the disease is neoplasm.